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Accelerated Graft Arteriosclerosis Is Enhanced by Sensitization of the 
Recipient to Donor Lymphocytes 
D.V. Cramer, S. Qian, J. Harnaha, F.A. Chapman, T.E. Starzl, and L. Makowka 
THE DEVELOPMENT of arteriosclerosis is the most 
serious and common complication in long-term survi-
vors of cardiac transplantation.! We recently have demon-
strated that heart grafts exchanged between inbred rat 
strains with selected histocompatibility differences develop 
accelerated graft arteriosclerosis. 2 Heterotopic cardiac al-
lografts were exchanged between strains that differed for 
MHC class I (RTl.A or RTl.E) antigens or groups of minor, 
non-MHC antigens in MHC-compatible congenic combina-
tions. In combinations in which the allograft reaction is mild 
and prolonged, the donor hearts exhibit pathological changes 
that include a diffuse, interstitial myocardial fibrosis, perivas-
cular fibrosis, and intimal proliferation in arteries of the graft 
myocardium. The results suggested that the comparable 
pathological changes seen in long-term human cardiac survi-
vors may reflect low-level, persistent allograft reactions 
rather than factors associated with graft anoxia or effects of 
immunotherapy to prevent graft rejection. 
The observation that accelerated graft arteriosclerosis 
could be induced as the result of low-level, persistent al-
lograft reactions suggests that manipulations of this allograft 
reaction should be associated with alterations in the severity 
or prevalence of the lesions in the heart graft. In the studies 
reported here, we have extended these early observations to 
examine the influence of immunization of recipient animals 
with donor tissues on the pathological lesions in the donor 
heart. 
MATERIALS AND METHODS 
Adult rats (10-16 weeks of age) bred in our colony at the University 
of Pittsburgh School of Medicine or LEW rats purchased from 
Harlan-Sprague-Dawley (Indianapolis. IN) were used in this study. 
The donor and recipient strains represented two combinations of 
MHC-matched congenic pairs (BN.IA ~ DA and DA.IN ~ BN) 
that differ for BN and DA strain minor histocompatibility antigens. 
respectively. A third combination. LEW ~ F344, is two strains that 
are matched for the major class I and II of the rat MHC. The rats 
were housed under conventional conditions and fed ra t chow (Wayne 
Lab-Blox F-6, Chicago, IL), and tap water ad libitum. Intraabdomi-
nal heterotopic cardiac grafting was performed using a modification 
of the techniques described by Ono and Lindsey.) The donor animals 
were anesthetized with sodium pentobarbital (40 mg/kg i.p.) and 
maintained on methoxyflurane via inhalation. The vena cavae and 
pulmonary veins were ligated with 5-0 silk, and the pulmonary artery 
and aorta were transected 2-3 mm above their origins in the heart. 
After perfusion of the ventricles and atria with lactated Ringer's 
solution (containing 200 U Iml of heparin), the heart was placed in a 
saline bath at 4°C. Recipient animals were anesthetized with 
pentobarbital, a midline incision made, and the great abdominal 
vessels were dissected free from the left renal vein to the bifurcation. 
The graft was implanted in the abdominal cavity, with both 
anastomoses done in a running end-to-side fashion with 10-0 Novafil 
Table 1. Effect of Histocompatibility Differences on 
Accelerated Arteriosclerosil 
Histopathology 
Incompatibility n VtP" VAS MF MI 
BN.1A ~ DA 
3 months PT 6 ++ + +++ ++ 
6 months PT 5 +++ ++ ++ ++ 
aAK1k~ BN 
3 months PT 10 ++ ++ +++ +++ 
LEW ~ F344 
49-90 days PT 8 ++ +++ ++++ ++++ 
·VIP, vascular intimal proliferation; VAS. vasculitis; MF, myocar-
dial fibrosis; MI, myocardial innammation; PT. posttransplant. 
on a TE-IO needle. Operative times ranged from 30 to 45 minutes, 
with a success rate of approximately 90%. The function of the 
heterotopic grafts was monitored by abdominal palpation, and the 
grafts were removed when they ceased to function or had reached the 
appropriate time posttransplantation. All grafts were fixed in 10% 
buffered formalin, biventricular sections of the myocardium were 
submitted for paraffin embedding and processing, and the sections 
were stained with H&E. 
RESUL TS AND DISCUSSION 
As we have reported previously, the BN.I AIDA and DA.I NI 
BN strain combinations differ for weak histocompatibility 
differences that allow for prolonged graft survival and the 
development of accelerated graft arteriosclerosis. 2 When the 
grafts are allowed to remain for longer periods of time. the 
severity and incidence of the vascular lesions increase. In the 
BN.IA ~ DA combination. we expect to see approximately 
50% of the grafts with mild to moderate lesions of arterioscle-
rosis in several vessels (Table I). In the grafts that were 
harvested at 6 months posttransplantation. 4/5 grafts exhib-
ited myointimal proliferative changes that were classified as 
moderate to severe. The LEW - F344 combination has been 
reported by others' to induce accelerated arteriosclerosis. 
and this combination was included in these studies for 
comparison to our congenic models (Table I). In general, the 
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ACCELERATED GRAFT ARTERIOSCLEROSIS 
Table 2. Changes In Accelerated Arteriosclerosis Following 
Immunization 
Histopathology 
Incompatibility n VIp· VAS t.4F 1.41 NEe 
BN.1A-OA 
3 months PT 6 ++ + +++ ++ 
Skin graft 3 ++++ 
lAK1k~Bk 
3 months PT 10 ++ ++ +++ +++ 
Skin grafts 4 + + +++ +++ 
Splenic lymphs 7 +++ +++ ++++ ++++ 
'VIP, vascular intimal proliferation; VAS, vasulitis; MF, myocar· 
dial fibrosis; MI, myocardial inftammation; PT, posttransplant; 
NEC, acute hemorrhagic necrosis. 
prevalence and severity of the lesions in this combination 
were similar to those seen with the two congenic combina· 
tions, although the inflammatory component of the intimal 
lesion was more pronounced, and a more severe rejection 
reaction resulted in the failure of 5/8 grafts at days 49-50 
post transplan tation. 
The effect of sensitization of the recipient to donor tissues 
was examined by placing a single skin graft from the BN.I A 
or DA.I N donor strains on DA or BN recipients I month 
before cardiac transplantation (Table 2). In the BN.IA ~ 
DA combination, this level of sensitization was sufficient to 
precipitate an acute rejection of the heart grafts. The grafts 
were rejected within 6 to 12 days and were characterized 
histologically by hemorrhagic necrosis of the grafted tissue. 
Sensitization via skin grafting in the DA.I N ~ BN combina-
tion resulted in a more severe cell-mediated rejection reac-
tion, including a more severe vasculitis of the graft vessels 
and myocardial inflammatory disease. The severity and 
prevalence of the intimal lesions, however, were not acceler-
ated and were less extensive than those seen in the 3-month 
3715 
control animals. These results suggest that the skin graft may 
not express the antigen(s) that serve as the target for the 
allograft reaction in this combination. 
The BN recipient animals also were sensitized to the 
DA.I N donors by a single i.p. injection of I x 106 splenic 
lymphocytes 3 weeks before transplantation. This type of 
sensitization produced a more severe myocardial inflamma-
tory reaction, vasculitis, and the appearance of a more 
pronounced myointimal proliferation in the graft vessels 
(Table 2). 
We believe that the results of these experiments demon-
strate that accelerated arteriosclerosis can be induced exper-
imentally in cardiac allografts by grafting across a variety of 
weak histocompatibility barriers. This type of tissue incom-
patibility may allow for prolonged graft survival and the 
stimulation of myointimal proliferative changes secondary to 
a low-level rejection reaction directed, at least in part, at the 
vascular endothelium. 
The arteriosclerosis can be stimulated by both MHC and 
non-MHC antigens and increases in severity in proportion to 
the length of the posttransplant period and the level of 
sensitization of the recipient to selected donor tissues. We 
anticipate that more careful selection of human donor-
recipient pairs for cardiac transplantation and better control 
of allograft immunosuppression should prevent the develop-
ment of this important complication of cardiac transplanta-
tion. 
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